Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 References  













Kebuzone






●فارسی
 ●Magyar
 ●Српски / srpski
 ●Srpskohrvatski / српскохрватски
 ●Tiếng Việt
  
Edit links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  

Kebuzone
Clinical data
Routes of
administration		intramuscular
ATC code
Pharmacokinetic data
Elimination half-life70–100 hours
Excretionrenal
Identifiers

  • 4-(3-oxobutyl)-1,2-di(phenyl)pyrazolidine-3,5-dione

CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
CompTox Dashboard (EPA)
ECHA InfoCard100.011.560 Edit this at Wikidata
Chemical and physical data
FormulaC19H18N2O3
Molar mass322.364 g·mol−1
3D model (JSmol)

  • CC(=O)CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3

  • InChI=1S/C19H18N2O3/c1-14(22)12-13-17-18(23)20(15-8-4-2-5-9-15)21(19(17)24)16-10-6-3-7-11-16/h2-11,17H,12-13H2,1H3 ☒N

  • Key:LGYTZKPVOAIUKX-UHFFFAOYSA-N ☒N

 ☒NcheckY (what is this?)  (verify)

Kebuzone (orketophenylbutazone) is a nonsteroidal anti-inflammatory drug (NSAID) that is used for the treatment of inflammatory conditions such as thrombophlebitis and rheumatoid arthritis (RA).[1][2][3]

References[edit]

  1. ^ Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. 2018. Rheumesser 3 ml-Ampullen.
  • ^ "KEBUZONE". NCATS Inxight: Drugs. Retrieved 2019-02-27.
  • ^ Aronson JK (2016). "Kebuzone". Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (Sixteenth ed.). Amsterdam. p. 405. ISBN 978-0-444-53716-4.{{cite book}}: CS1 maint: location missing publisher (link)



    • Stub icon

    This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.

  • t
  • e

    • Retrieved from "https://en.wikipedia.org/w/index.php?title=Kebuzone&oldid=1182078097"
    Categories: 
    ●Ketones
     ●Pyrazolidindiones
     ●Nonsteroidal anti-inflammatory drugs
     ●Musculoskeletal system drug stubs
     Hidden categories: 
    ●CS1 German-language sources (de)
     ●CS1 maint: location missing publisher
     ●Articles with short description
     ●Short description is different from Wikidata
     ●Articles with changed DrugBank identifier
     ●Articles with changed ChemSpider identifier
     ●Articles with changed EBI identifier
     ●ECHA InfoCard ID from Wikidata
     ●Articles with changed InChI identifier
     ●Drugs with no legal status
     ●Drugboxes which contain changes to verified fields
     ●Drugboxes which contain changes to watched fields
     ●All stub articles
      


    ●This page was last edited on 27 October 2023, at 00:18 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki